期刊
CLINICAL SCIENCE
卷 112, 期 5-6, 页码 265-280出版社
PORTLAND PRESS LTD
DOI: 10.1042/CS20060242
关键词
cirrhosis; collagen; fibrosis; hepatic stellate cell; inflammation; liver; myofibroblast
资金
- MRC [G0600033] Funding Source: UKRI
- Medical Research Council [G0600033] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Liver fibrosis represents a major worldwide health care burden. The last 15 years have seen a rapid growth in our understanding of the pathogenesis of this clinically relevant model of inflammation and repair. This work is likely to inform the design of effective antifibrotic therapies in the near future. In this review, we examine how the innate and adaptive immune response interacts with other key cell types in the liver, such as the myofibroblast, regulating the process of hepatic fibrosis and, where relevant, resolution of fibrosis with remodelling. Emphasis is placed on the increasing knowledge that has been generated by the use of transgenic animals and animals in which specific cell lines have been deleted. Additionally, we review the increasing evidence that, although significant numbers of wound-healing myofibroblasts are derived from the hepatic stellate cell, significant contributions may occur from other cell lineages, including those from distant sites such as bone marrow stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据